Smallpox

Pharma

Emergent finalizes deal for Chimerix's smallpox drug Tembexa

Emergent BioSolutions completed its acquisition of oral antiviral Tembexa from Chimerix, giving the U.S. another potential treatment for monkeypox.
Kevin Dunleavy Sep 27, 2022 9:15am

FDA says overuse of Siga's Tpoxx could render it ineffective

Sep 15, 2022 10:54am

HHS earmarks $680M for smallpox drug, an Emergent buyout target

Aug 29, 2022 11:50am

U.S. orders another 2.5 million doses of Jynneos vaccine

Jul 18, 2022 10:49am

The US is ordering up more doses of the monkeypox shot Jynneos

Jul 5, 2022 9:00am

Amid monkeypox outbreak, Siga nabs $13M in smallpox drug orders

Jun 23, 2022 10:54am